Rakovina Therapeutics Inc. | Finanzwire

Basculer en Français

11191	Companies
247555	Keywords
175386	Articles
133782	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 09/02/2026 at 18:53, 1 month 14 days ago

Rakovina Therapeutics Inc. Receives Downgrade from First Berlin Equity Research

Licensing Deal Price Target Revision Rakovina Therapeutics AI-powered Pipeline Kt-5000 Program
PRESS RELEASE

published on 09/02/2026 at 18:48, 1 month 14 days ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add
First Berlin Equity Research downgrades Rakovina Therapeutics Inc. to ADD and lowers price target to CAD 0.25 in latest research update

First Berlin Equity Research Research Update Price Target Rakovina Therapeutics Inc. Stock Downgrade
BRIEF

published on 04/02/2025 at 15:36, 1 year 6 months ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
PRESS RELEASE

published on 04/02/2025 at 15:31, 1 year 6 months ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 10/17/2026 at 03:20, 10 hours 13 minutes ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 10 hours 18 minutes ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 13 hours 58 minutes ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 14 hours 3 minutes ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 14 hours 33 minutes ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

EQS Group

Published on 10/17/2026 at 13:05, 28 minutes ago

Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 43 minutes ago

AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 17 hours 24 minutes ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 18 hours 12 minutes ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 18 hours 28 minutes ago

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers

Les Echos

Published on 10/16/2026 at 18:48, 18 hours 44 minutes ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 07:30, 1 day 6 hours ago

Third Quarter Revenues 2026
Published on 10/15/2026 at 18:50, 1 day 18 hours ago

September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 1 day 19 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 17:45, 1 day 19 hours ago

VOGO : H1 2026 results.

View all LES ECHOS COMFI WIRE